PaulJ.LemarbreMD

Oncology • Oconomowoc, WI

Physician

Join to view full profile

Are you Dr. Lemarbre?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 42 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
W359n7430 Brown St
Oconomowoc, WI 53066
Phone+1 262-468-0115
Is this information wrong?

Summary

Dr. Paul Lemarbre, MD is an oncologist in Oconomowoc, Wisconsin. He is currently licensed to practice medicine in Wisconsin, Alabama, and Vermont. He is affiliated with ProHealth Waukesha Memorial Hospital and Froedtert and the Medical College of Wisconsin Froedtert Hospital.

Education & Training

Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalFellowship, Hematology and Medical Oncology, 1979 - 1980
University of MinnesotaFellowship, Hematology and Medical Oncology, 1977 - 1979
University of MinnesotaResidency, Internal Medicine, 1976 - 1977
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Internal Medicine, 1974 - 1976
University of Minnesota Medical SchoolClass of 1974

Certifications & Licensure

WI State Medical License 1991 - 2023
AL State Medical License 2015 - 2016
VT State Medical License 1987 - 1992
MN State Medical License 1976 - 1979
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Publications & Presentations

PubMed

1 citations
Phase II trial of tamoxifen, etoposide, mitoxantrone, and cisplatin in patients with metastatic breast carcinoma.
Suzanne D. Conzen, Peter A. Kaufman, Christine Arvizu, Paul LeMarbre, L. Herbert Maurer, Leila A. Mott, Letha E. Mills> ;Cancer. 1996 Nov 1
11 citations
Metastatic islet cell amphicrine carcinoma of the pancreas. Association with an eosinophilic infiltration of the skin.
Wayne D. Kniffin, Steven K. Spencer, Vincent A. Memoli, Paul J. LeMarbre> ;Cancer. 1988 Nov 1
32 citations
Lysozyme enhances monocyte-mediated tumoricidal activity: a potential amplifying mechanism of tumor killing.
Paul Lemarbre, John J. Rinehart, Neil E. Kay, Robert Vesella, Harry S. Jacob> ;Blood. 1981 Nov 1
Human pulmonary macrophage tumor cell cytotoxicity.
Lemarbre, P., Hoidal, J., Vesella, R., Rinehart, J.> ;Blood. 1980 Apr
Combination chemotherapy with cisplatin, carmustine, dacarbazine, and tamoxifen in metastatic melanoma.
Del Prete, S. A., Maurer, L. H., O'Donnell, J., Forcier, R. J., LeMarbre, P.> ;Cancer Treat Rep. 1984 Nov
Dacarbazine, cisplatin and carmustine, with or without tamoxifen, for metastatic melanoma: 5-year follow-up.
Lattanzi, S. C., Tosteson, T., Chertoff, J., Maurer, L. H., O'Donnell, J., LeMarbre, P. J., Mott, L., DelPrete, S. A., Forcier, R. J., Ernstoff, M. S.> ;Melanoma Res. 1995 Oct
Combined modality approach in the management of locally advanced head and neck cancer.
Coughlin, C. T., Grace, M., O'Donnell, J. F., LeMarbre, P. J., Morain, W. D., Geurkink, N. A., McIntyre, O. R.> ;Cancer Treat Rep. 1984 Apr
9 citations
Spurious E rosette formation in B cell chronic lymphocytic leukemia due to monoclonal anti-sheep RBC antibody
Letha E. Mills, Joseph F. O'Donnell, Paul M. Guyre, Paul J. LeMarbre, Janelle D. Miller, George M. Bernier> ;Blood. 1985 Feb 1
Join now to see all

Hospital Affiliations

Froedtert and the Medical College of Wisconsin Froedtert HospitalMilwaukee, Wisconsin
ProHealth Waukesha Memorial HospitalWaukesha, Wisconsin